A phase II study of the early clinical trials group (EORTC). Invest New Drugs 3: 63-66.Falkson, G.; Vorobiof, D.A. Epirubicin in Colorectal Cancer. In Advances in Anthracycline Chemotherapy: Epirubicin; Bonadonna, G., Ed.; Masson Italia Editori: Roma, Italy, 1984; pp. 105-109....
it is also very expensive, both for the pharma company but also ultimately, the healthcare systems that pay for the drugs. If you can make similar breakthroughs and achieve
We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with...
Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China Tel + 86 731 8529 2064 Fax + 86 731 8529 2060 Email zdong@gru.edu Abstract: Paclitaxel (Taxol), one of the most important anticancer drugs, has been used for therapy of different types of cancer...
Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China Tel + 86 731 8529 2064 Fax + 86 731 8529 2060 Email zdong@gru.edu Abstract: Paclitaxel (Taxol), one of the most important anticancer drugs, has been used for therapy of different types of cancer...
学术范收录的Journal Encouraging New Uses for Old Drugs.,目前已有全文资源,进入学术范阅读全文,查看参考文献与引证文献,参与文献内容讨论。学术范是一个在线学术交流社区,收录论文、作者、研究机构等信息,是一个与小木虫、知乎类似的学术讨论论坛,也是一个与中国
Decreased synthesis of NO in the uterus is associated with initiation of labour in an- imals. A recent study explored the use of nitroglycerin Douglas: NEW DRUGS, OLD DRUGS AND THE OBSTETRIC ANAESTHETIST R5 patches applied to the abdomen to inhibit preterm la- bour. H The patches were ...
Currently, there are no Food and Drug Administration (FDA)-approved drugs to treat COVID-19. In the absence of effective treatment, off-label drug use, in lieu of evidence from published randomized, double-blind, placebo-controlled clinical trials, is common in COVID-19. Although it is ...
Over the past decade, Schering-Plough Corp.'s Claritin brand of allergy drugs have reaped about $9 billion in total worldwide revenue. It's no wonder, then, that the company would do whatever it takes to keep the franchise on its best-selling medicine go
New Drugs, Old Drugs There is mounting urgency to find new drugs for the treatment of serious infectious diseases and cancer that are rapidly developing resistance to previousl... RJ Stark,CD Stark 被引量: 1发表: 2008年 New uses for old drugs Existing therapies are often tried when new dis...